| TRIM25 has a dual function in the p53/Mdm2 circuit P Zhang, S Elabd, S Hammer, V Solozobova, H Yan, F Bartel, S Inoue, ... Oncogene 34 (46), 5729-5738, 2015 | 83 | 2015 |
| POSSIBLE NEUROENDOCRINE ROLE FOR OXYTOCIN IN BONE REMODELING ZK ELABD S.K. , SABRY I. , HASSAN W.B. , NOUR H. ENDOCRINE REGULATIONS 41, 131–141, 2007 | 54 | 2007 |
| Two birds with one stone: possible dual-role of oxytocin in the treatment of diabetes and osteoporosis S Elabd, I Sabry Frontiers in endocrinology 6, 121, 2015 | 42 | 2015 |
| TRIMming p53’s anticancer activity S Elabd, G Meroni, C Blattner Oncogene 35 (43), 5577-5584, 2016 | 40 | 2016 |
| Oxytocin as a novel therapeutic option for type I diabetes and diabetic osteopathy S Elabd, S Sabry, M Mohasseb, A Algendy ENDOCRINE REGULATIONS 48, 87–102, 2014 | 26 | 2014 |
| Fam83F induces p53 stabilisation and promotes its activity M Salama, D Benitez-Riquelme, S Elabd, L Munoz, P Zhang, ... Cell Death & Differentiation 26 (10), 2125-2138, 2019 | 17 | 2019 |
| Delay in development and behavioural abnormalities in the absence of p53 in zebrafish S Elabd, NA Jabeen, V Gerber, R Peravali, JC Bourdon, S Kancherla, ... PLoS One 14 (7), e0220069, 2019 | 13 | 2019 |
| Expression screening using a Medaka cDNA library identifies evolutionarily conserved regulators of the p53/Mdm2 pathway P Zhang, AS Kratz, M Salama, S Elabd, T Heinrich, J Wittbrodt, C Blattner, ... BMC biotechnology 15, 1-9, 2015 | 8 | 2015 |
| Synergetic effect of tumor treating fields and zinc oxide nanoparticles on cell apoptosis and genotoxicity of three different human cancer cell lines MM Shawki, A El Sadieque, S Elabd, ME Moustafa Molecules 27 (14), 4384, 2022 | 7 | 2022 |
| P53 is active in human amniotic fluid stem cells M Rodrigues, I Antonucci, S Elabd, S Kancherla, M Marchisio, C Blattner, ... Stem Cells and Development 27 (21), 1507-1517, 2018 | 7 | 2018 |
| Tumor treating fields (TTFs) using uninsulated electrodes induce cell death in human non-small cell lung carcinoma (NSCLC) cells. MM Shawki, S Elabd AIMS Biophysics 8 (2), 2021 | 2 | 2021 |
| Tripartite Motif Proteins-A Protein Family Strongly Linked to Cancer S Elabd, ACB Cato, C Blattner Ann Pharmacol Pharm. 2017; 2 (10) 1057, 2017 | 1 | 2017 |
| Kock continent ileal reservoir and the urethral Kock bladder substitute OM ABUFARHA, F Hamoud, M ELGARBAWY, S ELABD, M ELSHARABI, ... JOURNAL OF UROLOGY 135 (4), A372-A372, 1986 | 1 | 1986 |
| Evening primrose oil sensitized cisplatin potential in A549 lung cancer cells via activation of p53 pathway M Salama, S Elabd, A Ali, NA Matar Egyptian Journal of Basic and Applied Sciences 11 (1), 557-567, 2024 | | 2024 |
| Citalopram, an antipsychotic agent, induces G1/G0 phase cell cycle arrest and promotes apoptosis in human laryngeal carcinoma HEP-2 cells M Salama, A Ali, FAR Ibrahim, S Elabd Medical Oncology 41 (5), 105, 2024 | | 2024 |
| TRIM25 targets p300 for degradation S Elabd, E Pauletto, V Solozobova, N Eickhoff, N Padrao, W Zwart, ... Life Science Alliance 6 (12), 2023 | | 2023 |
| The Cytotoxicity of ZnO NPs on Breast Cancer Cell Lines MCF-7 Depending on the Dispersion Solution A El Sadieque, M Shawki, S Elabd, M Moustafa Physics of Particles and Nuclei Letters 19 (3), 282-284, 2022 | | 2022 |
| Expression screening using a Medaka cDNA library identifies evolutionarily conserved regulators of the p53/Mdm2 pathway. ZP Zhang Ping, AS Kratz, M Salama, S Elabd, T Heinrich, J Wittbrodt, ... | | 2015 |
| Expression screening using a Medaka cDNA library identifies evolutionarily conserved regulators of the p53/Mdm2 pathway G Davidson, C Blattner, J Wittbrodt, T Heinrich, S Elabd, M Salama, ... | | 2015 |
| URINARY-DIVERSION-THE CONTINENT CECAL BLADDER (GILCRIST) WITH KOCK CONTINENT VALVE OM ABUFARHA, F HAMOUD, M ELSHARABI, M ELGARBAWI, S ELABD JOURNAL OF UROLOGY 135 (4), A371-A371, 1986 | | 1986 |
